Skip to Content

Aspirin / carisoprodol Pregnancy and Breastfeeding Warnings

Aspirin / carisoprodol is also known as: Carisoprodol Compound, Soma Compound

Aspirin / carisoprodol Pregnancy Warnings

Use is not recommended unless clearly needed. US FDA pregnancy category D Comments: -Aspirin should be avoided after 30 weeks gestation as it may lead to premature closure of the fetal ductus arteriosus.

There are no animal reproduction studies with this combination product. Animal studies with carisoprodol have shown effects on fetal growth and postnatal survival. Salicylic products have shown to be teratogenic and embryocidal in rodents at doses considered much greater than usual therapeutic human doses. Aspirin use within 1 week of delivery or during labor may prolong delivery or lead to excessive blood loss in the mother or baby. There are no controlled data in human pregnancy. US FDA pregnancy category D: There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Aspirin / carisoprodol Breastfeeding Warnings

Aspirin is excreted as salicylic acid in breastmilk. Higher doses of aspirin appear to result in disproportionately higher milk levels. Reye's syndrome is associated with aspirin administration in infants with viral illnesses, however the risk from breastfeeding is unknown. Maternal use of carisoprodol may lead to reduced or less effective infant feeding due to sedation and/or decreased milk production. Alternative agents are recommended.

Breastfeeding is not recommended Excreted into human milk: Yes (aspirin); Yes (carisoprodol) Comment: -Most experts recommend against breastfeeding while taking aspirin, especially when using higher doses.

See references

References for pregnancy information

  1. "Product Information. Aspirin-Carisoprodol (aspirin-carisoprodol (acetylsalicylic acid-carisoprodol))." Heritage Pharmaceuticals Inc, Edison, NJ.

References for breastfeeding information

  1. "Product Information. Aspirin-Carisoprodol (aspirin-carisoprodol (acetylsalicylic acid-carisoprodol))." Heritage Pharmaceuticals Inc, Edison, NJ.
  2. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL:" ([cited 2013 -]):

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.